Huiqiang Huang
MD
Professor and Director, Department of Medical Oncology
👥Biography 个人简介
Huiqiang Huang leads one of China's largest NK/T-cell lymphoma programs and has contributed seminal data on the DDGP (dexamethasone, cisplatin, gemcitabine, PEG-asparaginase) regimen as a frontline treatment for advanced NK/T-cell lymphoma. His large cohort studies from Sun Yat-sen Cancer Center have provided important outcome data that compare favorably with SMILE and have influenced Asian practice guidelines.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Huiqiang Huang 的研究动态
Follow Huiqiang Huang's research updates
留下邮箱，当我们发布与 Huiqiang Huang（Sun Yat-sen University Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment